PlumX Metrics
Embed PlumX Metrics

Nanoparticles exposing neurotensin tumor-specific drivers

Journal of Peptide Science, ISSN: 1075-2617, Vol: 19, Issue: 4, Page: 198-204
2013
  • 20
    Citations
  • 0
    Usage
  • 9
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

Nanoparticles have attracted much attention for their potential application as in vivo carriers of drugs. Labeling of nanoparticles with bioactive markers that are able to direct them toward specific biological target receptors has led to a new generation of drug delivery systems. In particular, low molecular weight peptides that remain stablein vivo could be promising tools to selectively drive nanoparticles loaded with active components to tumor cells. We reported, recently, that tetrabranched neurotensin peptides (NT4) may be used to selectively target tumor cells with liposomes. Liposomes functionalized with tetrabranched neurotensin peptide, NT4, and loaded with doxorubicin showed clear advantages in cell binding, anthracyclin internalization, and cytotoxicity in respect of not functionalized liposomes. In this study, we compare branched (NT4) versus linear (NT) peptides in the ability to drive liposomes to target cells and deliver their toxic cargo. We showed here that the more densely decorated liposomes had a better activity profile in terms of drug delivery. Presentation of peptides to the cell membranes in the grouped shape provided by branched structure facilitates liposome cell binding and fusion. © 2013 European Peptide Society and John Wiley & Sons, Ltd.

Bibliographic Details

Falciani, Chiara; Brunetti, Jlenia; Lelli, Barbara; Accardo, Antonella; Tesauro, Diego; Morelli, Giancarlo; Bracci, Luisa

Wiley

Biochemistry, Genetics and Molecular Biology; Pharmacology, Toxicology and Pharmaceutics; Chemistry

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know